CN117257664A - 一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 - Google Patents
一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 Download PDFInfo
- Publication number
- CN117257664A CN117257664A CN202310556041.8A CN202310556041A CN117257664A CN 117257664 A CN117257664 A CN 117257664A CN 202310556041 A CN202310556041 A CN 202310556041A CN 117257664 A CN117257664 A CN 117257664A
- Authority
- CN
- China
- Prior art keywords
- parts
- saccharification
- oxidation composition
- aging
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000003064 anti-oxidating effect Effects 0.000 title claims abstract description 45
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 45
- 235000009566 rice Nutrition 0.000 claims abstract description 45
- 239000000047 product Substances 0.000 claims abstract description 41
- 238000000855 fermentation Methods 0.000 claims abstract description 40
- 230000004151 fermentation Effects 0.000 claims abstract description 40
- 239000000706 filtrate Substances 0.000 claims abstract description 32
- 108010087806 Carnosine Proteins 0.000 claims abstract description 31
- HIXYEIRACBUSON-FJXQXJEOSA-N (2s)-2-(3-aminopropanoylamino)-3-(1h-imidazol-5-yl)propanoic acid;hydrochloride Chemical compound Cl.NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 HIXYEIRACBUSON-FJXQXJEOSA-N 0.000 claims abstract description 29
- 241000195493 Cryptophyta Species 0.000 claims abstract description 29
- 229940070763 carnosine hydrochloride Drugs 0.000 claims abstract description 29
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 17
- 230000001815 facial effect Effects 0.000 claims abstract description 12
- 230000003750 conditioning effect Effects 0.000 claims abstract description 11
- 241000209094 Oryza Species 0.000 claims description 44
- 239000003974 emollient agent Substances 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 15
- 239000011259 mixed solution Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000002738 chelating agent Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- 239000002562 thickening agent Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 4
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 4
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 229940057910 shea butter Drugs 0.000 claims description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 229940092738 beeswax Drugs 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 229940039717 lanolin Drugs 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- 229940045136 urea Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 241000221095 Simmondsia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- 230000037303 wrinkles Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 5
- 108010022355 Fibroins Proteins 0.000 abstract description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract description 3
- 238000005282 brightening Methods 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 239000000835 fiber Substances 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 230000037319 collagen production Effects 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 30
- 230000000052 comparative effect Effects 0.000 description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 230000032683 aging Effects 0.000 description 9
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 230000009759 skin aging Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 238000006206 glycosylation reaction Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 229940123457 Free radical scavenger Drugs 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 101710130006 Beta-glucanase Proteins 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- 241000199914 Dinophyceae Species 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 235000020195 rice milk Nutrition 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- -1 sulfur polysaccharide Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 102000015785 Serine C-Palmitoyltransferase Human genes 0.000 description 1
- 108010024814 Serine C-palmitoyltransferase Proteins 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明属于日用化妆品技术领域,公开了一种抗糖化抗氧化组合物、抗衰面霜及其制备方法。本发明所述抗糖化抗氧化组合物包括如下重量份的成分:0.1~1.5份脱羧肌肽盐酸盐、0.2~10.4份藻提取物和0.1~12.5份酵母菌/大米发酵产物滤液。与现有技术相比,含有本发明所述抗糖化抗氧化组合物的抗衰面霜同时具有优异的抗糖化和抗氧化功效且吸收性好,能够减少氧化和糖化损伤、抑制基质金属蛋白酶降解,从而改善皱纹、提亮皮肤和促进胶原蛋白的生成。同时,本发明还具有保湿、补充肌肤丝聚蛋白或底层纤维,展现出优异的皮肤调理作用。
Description
技术领域
本发明属于日用化妆品技术领域,尤其是涉及一种抗糖化抗氧化组合物、抗衰面霜及其制备方法。
背景技术
皮肤衰老是一种复杂的生理过程,其临床表现为皮肤皱纹、粗糙、干燥、皮肤松弛和下垂,以及色素沉淀等。人类的皮肤老化分为内源性老化和外源性老化。内源性老化是随着年龄增长而自然发生的老化过程,受每个人的遗传因素影响,个体差异较大。例如,人体新陈代谢速度会随着年龄的增长而逐渐变慢,导致非酶糖基化反应增强,晚期糖基化终末产物质(AGEs)在体内不断累积,导致真皮层胶原蛋白和弹性蛋白参与糖化反应发生交联,使得皮肤弹性下降,影响其正常功能,从而出现皱纹并出现各种衰老现象。此外,AGEs能够与蛋白质形成色素加合物,致使皮肤出现色素沉着现象,导致肤色暗沉发黄。
外源性老化是指皮肤受环境因素(主要是紫外线辐射)影响而引起的衰老变化。当皮肤长期暴露在紫外线和蓝光中,会使皮肤产生大量的活性氧,引起一系列的氧化损伤反应,如线粒体损伤凋亡、细胞核内DNA链断裂。同时,活性氧也会刺激细胞分泌大量细胞因子,如基质金属蛋白酶,从而破坏胶原合成、皮肤屏障破坏等,进一步加速皮肤的老化。越来越多的研究表明抗氧化是预防衰老的重要手段,因此,如果能够消除过多的氧化自由基,就能有效预防自由基引起的皮肤老化。此外,因氧化而产生的大量自由基在体内不断累积后,也会参与糖化反应,从而进一步加快AGEs的形成。因此,加入抗氧剂不仅能够有效阻断氧化链反应,减缓自由基的产生,也能够有效抑制糖化过程中AGEs的生成,进一步提高抗糖化效果。
然而,目前市面上已有抗衰产品不能同时兼顾抗糖化和抗氧化功效、吸收率低、疗效不显著、成分复杂,因此,仍然需要一种具有优异抗糖化抗氧化效果、能够抑制肤色暗黄的面霜产品。
发明内容
本发明的目的就是为了克服上述现有技术存在的缺陷而提供一种抗糖化抗氧化组合物、抗衰面霜及其制备方法。
本发明的目的可以通过以下技术方案来实现:一种抗糖化抗氧化组合物,包括如下重量份的成分:0.1~1.5份脱羧肌肽盐酸盐、0.2~10.4份藻提取物和0.1~12.5份酵母菌/大米发酵产物滤液。
作为本发明的进一步优选,所述糖化抗氧化组合物由如下重量份的成分组成:0.2~1.2份脱羧肌肽盐酸盐、0.4~8.2份藻提取物和1.0~10.4份酵母菌/大米发酵产物滤液。
作为本发明的进一步优选,所述糖化抗氧化组合物由如下重量份的成分组成:0.4~1.0份脱羧肌肽盐酸盐、1.0~6.0份藻提取物和2.0~9.0份酵母菌/大米发酵产物滤液。
作为本发明的进一步优选,所述抗糖化抗氧化组合物包括如下重量份的成分:0.5~1.0份脱羧肌肽盐酸盐、2.1~4.5份藻提取物和5.0~7.0份酵母菌/大米发酵产物滤液。
脱羧肌肽盐酸盐,是肌肽发生脱羧反应的产物,不仅具有肌肽清除自由基、抗氧化、抗糖化等功效,还在特定的生理环境下具有比肌肽更加稳定的性质。脱羧肌肽盐酸盐不仅可用于皮肤祛黄和肤色提亮,还能预防皮肤过早衰老、维持皮肤年轻状态。此外,脱羧肌肽盐酸盐还能够用于对抗外界紫外线、污染物等不良环境对皮肤的侵袭,保护DNA,增加细胞新陈代谢恢复细胞活力,促进胶原蛋白的生成。
藻提取物含有富硫多糖,可以作为硫供体,促进谷胱甘肽的生成,因此具有优异的抗氧化性能,可强化皮肤自有抗氧化系统,减少氧化损伤、抑制基质金属蛋白酶降解,从而改善皱纹和提亮皮肤。藻提取物优选沟鞭微藻提取物,其含有丰富的硫多糖物质,能够提供保护细胞免受污染损害的屏障,同时也能够刺激细胞内清道夫-谷胱甘肽的生成,净化细胞的同时延缓细胞衰老。
酵母菌/大米发酵产物滤液具有成膜和保湿的作用,不仅能够帮助重建皮肤真皮基质的屏障作用,还能够补充皮肤自身的丝聚蛋白或底层纤维,具有皮肤调理的作用。此外,酵母菌/大米发酵产物滤液富含多种天然养肤成分且具有优异的亲肤性(接触性比水小),具有良好的渗透性,可以促进后续活性成分的吸收。
本发明一个实施方式中,具体提供一种酵母菌/大米发酵产物滤液的制备方法,包括以下步骤:
(1)大米粉末加水加热,搅拌,成为米浆,在米浆中加入β-葡聚糖酶,酶的添加量为米浆质量的0.001%~0.5%,酶活为150~200U/g,进行酶解,获得米浆酶解液;
(2)将酵母菌种Saccharomyces veronae接种米浆酶解液中,发酵的条件为:发酵温度20~40℃,发酵时间24~48小时,发酵过程pH控制为6~6.5,发酵后获得发酵液;
(3)发酵液通过反渗透技术浓缩,高效富集活性物质,经过加温杀菌,冷却过滤得到酵母菌/大米发酵产物滤液。
酵母菌/大米发酵产物滤液含有包括氨基酸、多糖、多胺、核酸和矿物质等90多种营养成分,能够促进促进丝聚蛋白、内披蛋白和丝氨酸棕榈酰转移酶的表达,还能促进表皮细胞的构建和天然保湿因子的增加,从而加速细胞代谢,延缓内源衰老。
作为本发明的进一步优选,本发明还提供一种抗衰面霜,所述抗衰面霜包含抗糖化抗氧化组合物。
作为本发明的进一步优选,所述抗糖化抗氧化组合物在抗衰面霜中的含量为0.4~24.4wt%。
作为本发明的进一步优选,所述抗糖化抗氧化组合物在抗衰面霜中的含量为5~15wt%。
作为本发明的进一步优选,所述抗衰面霜还包含螯合剂、保湿剂、皮肤调理剂、润肤剂、乳化剂、增稠剂、防腐剂中的至少一种。
作为本发明的进一步优选,所述螯合剂为EDTA二钠;所述保湿剂包含甘油、透明质酸钠、1,3-丁二醇、海藻糖、蜂蜜、肌醇、尿素、泛醇和甜菜碱中的至少一种;所述皮肤调理剂包含神经酰胺、泛酸、对羟基苯乙酮中的至少一种;所述润肤剂包含角鲨烯、霍霍巴籽油、蓖麻油、牛油果树油、辛酸/癸酸甘油三酯、鲸蜡硬脂醇、蜂蜡、牛油果树果脂中的至少一种;所述乳化剂包含卵磷脂、羊毛脂、羊毛醇、鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷、甘油硬脂酸酯中的至少一种;所述增稠剂包含黄原胶、卡波姆、改性淀粉、高分子聚合物中的至少一种;所述防腐剂包含苯氧乙醇、乙基己基甘油、戊二醇中的至少一种。
作为本发明的进一步优选,所述面霜还包含如下重量份的成分:抗糖化抗氧化组合物0.4~24.4份,螯合剂0.01~0.04份、保湿剂7.5~17份、皮肤调理剂0.5~3份、润肤剂2~7份、乳化剂1.2~10份、增稠剂0.1~2.0份、防腐剂0.1~0.5份。
作为本发明的进一步优选,所述抗衰面霜的制备方法包括如下步骤:
(1)将螯合剂、保湿剂、增稠剂和皮肤调理剂加入去离子水中,加热至80~90℃,均质、搅拌3~5min,得到混合液A;
(2)将乳化剂和润肤剂加热至80~90℃,待其完全溶解后,加入混合液A中,均质、搅拌3~5min,得到混合液B;
(3)将混合液B降温至40~50℃,加入抗糖化抗氧化组合物的抗衰组合物和防腐剂,搅拌5~15min,过滤,即可得到所述抗衰面霜。
与现有技术相比,本发明具有以下优点及有益效果:
(1)本发明含有脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液等多种具有抗氧化、抗糖化和保湿的活性成分,各活性成分之间彼此协同,能够实现优异的抗糖化抗氧化效果。
(2)酵母菌/大米发酵产物滤液富含多种天然养肤成分且具有优异的亲肤性(接触性比水小),具有良好的渗透性,可以促进活性成分脱羧肌肽盐酸盐、藻提取物的吸收,更好地发挥抗糖化抗氧化作用。
(3)本发明的抗糖化抗氧化功效成分组合物,优选脱羧肌肽盐酸盐和藻提取物,化妆品通过优选组合以及功效测试,选择最优选组合物比例,最大程度发挥发挥抗糖化抗氧化作用;同时,搭配酵母菌/大米发酵产物滤液,帮助重建皮肤真皮基质的屏障作用和补充皮肤自身的丝聚蛋白或底层纤维。
具体实施方式
下列实施例进一步说明了本发明范围内的各种实施方案。这些实施例仅是为了说明目的而给出的,并不用来限定本发明,因为在不脱离本发明的精神和范围的情况下,可以对本发明进行许多变化。
本发明采用的所有原料如无特殊说明均为市售产品。酵母菌/大米发酵产物滤液可选用市售产品或按照本发明公开的方法获得。以下具体实施例中:
脱羧肌肽盐酸盐为四川吉晟生物医药有限公司的产品;
藻提取物为广州诺然生物科技有限公司的沟鞭微藻提取物产品;
酵母菌/大米发酵产物滤液按照如下方法制备:
(1)大米粉末加水加热,搅拌,成为30wt%米浆,在米浆中加入β-葡聚糖酶,酶的添加量为米浆质量的0.15%,酶活为200U/g,进行酶解,获得米浆酶解液;
(2)将酵母菌种saccharomyces veronae接种米浆酶解液中,发酵的条件为:发酵温度35℃,发酵时间36小时,发酵过程pH控制为6~6.5之间,发酵后获得米发酵液;
(3)发酵后的米发酵液通过反渗透技术浓缩10倍,高效富集活性物质,经过加温杀菌,冷却过滤得到浓缩后的米发酵液,即酵母菌/大米发酵产物滤液。
实施例1
本实施例所述抗糖化抗氧化组合物包括如下重量份的成分:0.2份脱羧肌肽盐酸盐、6.5份藻提取物和3.5份酵母菌/大米发酵产物滤液。
实施例2
本实施例所述抗糖化抗氧化组合物包括如下重量份的成分:0.5份脱羧肌肽盐酸盐、2.5份藻提取物和7.2份酵母菌/大米发酵产物滤液。
实施例3
本实施例所述抗糖化抗氧化组合物包括如下重量份的成分:0.8份脱羧肌肽盐酸盐、4.8份藻提取物和4.6份酵母菌/大米发酵产物滤液。
实施例4
本实施例所述抗糖化抗氧化组合物包括如下重量份的成分:0.6份脱羧肌肽盐酸盐、3.1份藻提取物和6.5份酵母菌/大米发酵产物滤液。
实施例5
本实施例所述抗糖化抗氧化组合物包括如下重量份的成分:1.0份脱羧肌肽盐酸盐、7.5份藻提取物和1.7份酵母菌/大米发酵产物滤液。
实施例6~10
实施例6~10为本发明所述抗衰面霜,其配方如表1所示;其中,实施例6~10所述抗衰面霜分别包含实施例1~5所述抗糖化抗氧化组合物。
表1实施例6~10的配方表(质量百分数%)
上述实施例6~10所述抗衰面霜的制备方法包括如下步骤:
(1)将螯合剂、保湿剂、增稠剂和皮肤调理剂加入去离子水中,加热至85℃,均质、搅拌5min,得到混合液A;
(2)将乳化剂和润肤剂加热至90℃,待其完全溶解后,加入混合液A中,均质、搅拌5min,得到混合液B;
(3)将混合液B降温50℃,加入抗糖化抗氧化组合物(将脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液混合后所得)和防腐剂,搅拌15min,过滤,即可得到所述抗衰面霜。
对比例1~5
对比例1~5为本发明所述抗衰面霜,其配方如表2所示,其制备方法和实施例9相同。
表2对比例1~5的配方表(质量百分数%)
性能测试
(1)抗糖化性能测试
糖基化反应发生在皮肤内部的还原糖与基质蛋白之间,是皮肤衰老的重要机制之一。非酶糖基化是一系列复杂的非酶促反应,蛋白质和还原糖(如葡萄糖)在体内发生非酶促反应形成早期糖基化产物,然后经过氧化、重排、交联等过程,最终形成不可逆的晚期糖基化终产物(AGEs),造成皮肤损伤和衰老。因此,能够有效清除AGEs的物质具有显著的抗衰老功效。
测试原理:AGEs可自发荧光,在特定波长下检测荧光强度,可以得到不同样品的抗糖化效果。
测试具体步骤如下:
(1)牛血清白蛋白(BSA)-葡萄糖建模:将0.05mol/L的磷酸缓冲盐溶液(PBS,pH=7.4),8mg/mL的BSA溶液及0.2mol/L的葡萄糖溶液在60℃下避光反应40h,得到BSA-葡萄糖糖化模型溶液(其中,PBS、牛血清白蛋白和葡萄糖浓度为混合溶液中的终浓度);
(2)取样:准确称取200mg各实施例和对比例得到的不同面霜样品(即受试样品)与300μL BSA-葡萄糖糖化模型溶液混合均匀,避光反应0.5-1h;
(3)样品荧光的检测:AGEs衍生的荧光可以通过磷酸缓冲盐溶液在370nm激发波长和440nm发射波长条件下检测;
(4)数据分析:AGEs抑制率(%)=[1-(A-B)/(C-D)]×100%
其中:A——添加受试样品的BSA-葡萄糖糖化模型溶液的荧光强度;
B——添加受试样品的超纯水溶液的荧光强度,即将步骤(2)中的300μL BSA-葡萄糖糖化模型溶液替换为300μL的超纯水;
C——没有受试样品,但有BSA-葡萄糖糖化模型溶液的荧光强度;即将步骤(2)中的200mg不同面霜样品替换为200mL的超纯水;
D——没有受试样品,没有BSA-葡萄糖糖化模型溶液的荧光强度,即为超纯水的荧光强度。
取三次测量平均值,测试结果如下表3所示:
表3不同面霜样品的抗糖化效果
项目 | 实施例6 | 实施例7 | 实施例8 | 实施例9 | 实施例10 |
AGEs抑制率(%) | 70.7 | 75.3 | 80.5 | 96.1 | 82.2 |
项目 | 对比例1 | 对比例2 | 对比例3 | 对比例4 | 对比例5 |
AGEs抑制率(%) | 34.3 | 34.4 | 34.2 | 16.4 | 16.3 |
从表3中实施例6~10抗糖化效果数据可知,只有面霜中同时添加脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液三种活性成分,且三种比例处于一定比例时,面霜才能最大程度发挥抗糖化效果。从表3中对比例1~5抗糖化效果数据可知,当未添加其中任一(两)种活性成分时,面霜抗糖化效果会大打折扣。上述结果表明,脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液能够协同作用,显著提高组合物的抗糖化性能。
(2)抗氧化性能测试
测试原理:利用DPPH法测试本发明中抗糖化抗氧化组合物对自由基的清除效果。DPPH又称1,1-二苯基-2-三硝基苯肼,具有单电子,在517nm处有一强吸收,其无水乙醇溶液呈紫色的特性。当有自由基清除剂存在时,由于与其单电子配对而使其吸收逐渐消失,其褪色程度与其接受的电子数量成定量关系,因而可用紫外-可见吸收光谱仪进行快速的定量分析。
DPPH自由基清除率测定实验测试方法:取实施例6-10和对比例1-5制备的抗衰面霜各2g,与8mL 1×10-4mol/L的DPPH/乙醇溶液混合,震荡均匀后于暗处避光反应30min(25℃),再将混合液置于离心机中,7000rpm离心5min,取离心后的上清液于517nm波长下测量吸光度A1;取2mL无水乙醇进行相同的操作,测量吸光度A2;取2mL去离子水进行相同的操作,测量吸光度A3。每组设置3组平行实验计算平均值。
根据DPPH清除率公式计算不同组别的抗氧化抗糖化组合物的自由基清除能力。DPPH清除率=[1-(A1-A2)/A3]×100%。DPPH清除率测试结果如表4所示。
表4不同面霜样品DPPH清除率测试结果
从表4实施例6-10和对比例1-5中DPPH清除率数据可知,只有面霜中同时添加脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液三种活性成分且处于合理比例时,面霜才能最大程度发挥DPPH自由基清除功效;当未添加其中任一(两)种活性成分时,面霜DPPH自由基清除功效会大打折扣。
(3)去皱抗衰功效测试
测试方法:选300名年龄为40-55岁的健康女性志愿者,分为10组,每组30人,将实施例6-10和对比例1-5的面霜分别给每组的健康志愿者使用。使用方法为每天早晚用清水洁面后在脸部涂抹一次,轻轻按压至吸收,连续使用28天,测试期间志愿者不允许使用其他任何产品。观察面部皱纹,皮肤变得显著紧致、皱纹明显减少为显效;脸部皮肤变得明显紧致,皱纹减少为有效;脸部皮肤没有改善的为无效,去皱效果如表5所示。
表5实施例6-10和对比例1-5制备的面霜去皱抗衰效果测试
从表5可知,对比例1较实施例9表明,当面霜中不添加脱羧肌肽盐酸盐时,连续使用28天后显效人数从25人(83%)降为2人(6%),表明脱羧肌肽盐酸盐对面霜抗衰效果至关重要;同时,对比例2较实施例9表明,当面霜中不添加藻提取物时,显效人数从25人(83%)降为2人(6%),表明藻提取物对面霜抗衰效果也是极为重要的;对比例3较实施例9表明,而当面霜中不添加酵母菌/大米发酵产物滤液时,显效人数从25人(83%)降为2人(6%)。
此外,实施例6~10和对比例1~6表明,只有面霜中同时添加脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液三种活性成分且处于优化比例时,面霜才能发挥最大抗衰功效,当未添加其中任一(两)种活性成分时,面霜抗衰效果都会大打折扣。这是因为合理比例的脱羧肌肽盐酸盐、藻提取物和酵母菌/大米发酵产物滤液三种活性成分协同后具有优异的抗糖化和抗氧化效果,能够最大程度发挥最佳去皱抗衰效果。综上所述,本发明所述的组合物具有抗糖化、抗氧化的双重功效,能够显著改善由于氧化及糖化引发的皮肤衰老问题。
上述的对实施例的描述是为便于该技术领域的普通技术人员能理解和使用发明。熟悉本领域技术的人员显然可以容易地对这些实施例做出各种修改,并把在此说明的一般原理应用到其他实施例中而不必经过创造性的劳动。因此,本发明不限于上述实施例,本领域技术人员根据本发明的揭示,不脱离本发明范畴所做出的改进和修改都应该在本发明的保护范围之内。
Claims (10)
1.一种抗糖化抗氧化组合物,其特征在于,包括如下重量份的成分:0.1~1.5份脱羧肌肽盐酸盐、0.2~10.4份藻提取物和0.1~12.5份酵母菌/大米发酵产物滤液。
2.根据权利要求1所述的一种抗糖化抗氧化组合物,其特征在于,所述抗糖化抗氧化组合物包括如下重量份的成分:0.2~1.2份脱羧肌肽盐酸盐、0.4~8.2份藻提取物和1.0~10.4份酵母菌/大米发酵产物滤液。
3.根据权利要求1所述的一种抗糖化抗氧化组合物,其特征在于,所述抗糖化抗氧化组合物包括如下重量份的成分:0.4~1.0份脱羧肌肽盐酸盐、1.0~6.0份藻提取物和2.0~9.0份酵母菌/大米发酵产物滤液。
4.根据权利要求1所述的一种抗糖化抗氧化组合物,其特征在于,所述抗糖化抗氧化组合物包括如下重量份的成分:0.5~1.0份脱羧肌肽盐酸盐、2.1~4.5份藻提取物和5.0~7.0份酵母菌/大米发酵产物滤液。
5.根据权利要求1所述的一种抗衰面霜,其特征在于,所述抗衰面霜包含如权利要求1~4任一项所述抗糖化抗氧化组合物。
6.如权利要求5所述的抗衰面霜,其特征在于,所述抗糖化抗氧化组合物在抗衰面霜中的含量为0.4~24.4wt%。
7.如权利要求5所述的抗衰面霜,其特征在于,所述抗衰面霜还包含螯合剂、保湿剂、皮肤调理剂、润肤剂、乳化剂、增稠剂、防腐剂中的至少一种。
8.如权利要求7所述的抗衰面霜,其特征在于,所述螯合剂为EDTA二钠;
所述保湿剂包含甘油、透明质酸钠、1,3-丁二醇、海藻糖、蜂蜜、肌醇、尿素、泛醇和甜菜碱中的至少一种;
所述皮肤调理剂包含神经酰胺、泛酸、对羟基苯乙酮中的至少一种;
所述润肤剂包含角鲨烯、霍霍巴籽油、蓖麻油、牛油果树油、辛酸/癸酸甘油三酯、鲸蜡硬脂醇、蜂蜡、牛油果树果脂中的至少一种;
所述乳化剂包含卵磷脂、羊毛脂、羊毛醇、鲸蜡硬脂醇/鲸蜡硬脂基葡糖苷、甘油硬脂酸酯中的至少一种;
所述增稠剂包含黄原胶、卡波姆、改性淀粉、高分子聚合物中的至少一种;
所述防腐剂包含苯氧乙醇、乙基己基甘油、戊二醇中的至少一种。
9.如权利要求7所述的抗衰面霜,其特征在于,包括如下重量份的成分:抗糖化抗氧化组合物0.4~24.4份,螯合剂0.01~0.04份、保湿剂7.5~17份、皮肤调理剂0.5~3份、润肤剂2~7份、乳化剂1.2~10份、增稠剂0.1~2.0份、防腐剂0.1~0.5份。
10.一种如权利要求9项所述抗衰面霜的制备方法,其特征在于,包括如下步骤:
(1)将螯合剂、保湿剂、增稠剂和皮肤调理剂加入去离子水中,加热至80~90℃,均质、搅拌3~5min,得到混合液A;
(2)将乳化剂和润肤剂加热至80~90℃,待其完全溶解后,加入混合液A中,均质、搅拌3~5min,得到混合液B;
(3)将混合液B降温至40~50℃,加入抗糖化抗氧化组合物和防腐剂,搅拌5~15min,过滤,即可得到所述抗衰面霜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310556041.8A CN117257664A (zh) | 2023-05-17 | 2023-05-17 | 一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310556041.8A CN117257664A (zh) | 2023-05-17 | 2023-05-17 | 一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117257664A true CN117257664A (zh) | 2023-12-22 |
Family
ID=89216619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310556041.8A Pending CN117257664A (zh) | 2023-05-17 | 2023-05-17 | 一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117257664A (zh) |
-
2023
- 2023-05-17 CN CN202310556041.8A patent/CN117257664A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108338965B (zh) | 一种五谷杂粮组合物及其制备方法 | |
CN113081890A (zh) | 一种具有抗糖抗氧化功能的精华液及其制作方法 | |
CN111096941A (zh) | 一种包含共生菌组合发酵物的美白组合物、美白精华及其制备方法 | |
CN114288216A (zh) | 一种抗氧化抗糖化组合物及其制备方法 | |
CN111603434A (zh) | 一种改善皮肤皱纹的组合物及其化妆品 | |
CN115054530B (zh) | 一种具有保湿抗衰老功效的护肤组合物及其制备方法 | |
CN114224768A (zh) | 修复抗衰组合物及其制备方法 | |
CN113712874A (zh) | 一种含水溶性硅素的护肤品及其制备方法和应用 | |
JP2023171950A (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
CN111000770A (zh) | 一种含珍珠肽的美白霜 | |
EP2763652B1 (fr) | Utilisation de glucanes obtenus a partir de prunus persica comme agent cosmetique anti-age | |
CN111603404B (zh) | 一种含细胞提取液的护肤精华液及其制备方法 | |
KR102654331B1 (ko) | 항 광노화, 진정 및 쿨링 효과를 가지는 발효 조성물 및 그 제조방법과 응용 | |
CN117257664A (zh) | 一种抗糖化抗氧化组合物、抗衰面霜及其制备方法 | |
CN111617025B (zh) | 美白祛斑抗糖化的发酵产物化妆品 | |
CN111743798B (zh) | 一种多效抗衰护肤品及其制备方法 | |
KR101997231B1 (ko) | 효소반응을 이용하여 제조된 꿀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
EP4368192A1 (en) | Combination of a lactobacillus strain and a grape extract for use as an anti-ageing agent | |
CN115105424B (zh) | 一种护肤用抗皱紧致活力素及其制备方法 | |
CN114983923B (zh) | 一种可同时抵抗内外源性衰老的皮肤外用组合物 | |
TWI838291B (zh) | 小葉冷水麻萃取物用以製備抗發炎的製劑的用途 | |
KR102608639B1 (ko) | 캡슐화케라틴의 제조방법 및 이의 방법으로 제조된 캡술화케라틴을 포함하는 피부장벽 개선용 화장료 조성물 | |
KR102379987B1 (ko) | 비타민e 유도체와 머루포도 추출물을 포함하는 피부 탄력 개선 및 피부 치밀도 개선용 화장품 조성물 | |
US20160317430A1 (en) | Cosmetic use of an extract of gymnema sylvestre | |
KR20090097232A (ko) | 가막살나무 추출물을 포함하는 피부주름 개선용 화장료조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |